MetaCap

Guardant Health Earnings

NASDAQ: GHHealth CareMedical SpecialitiesUSD

167.47+1.91 (+1.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 167.40 -0.04%

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.65

Guardant Health earnings summary

Guardant Health is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.65. In its most recent report on Jul 30, 2026 (Q2 2026), GH posted EPS of $-0.90. Revenue for the quarter was $335.0 million.

Across the last 16 reports, GH shares moved an average of 8.3% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

GH earnings history

Guardant Health reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 30, 2026—$-0.90—+4.0%
May 7, 2026—$-0.85—-0.8%
Feb 19, 2026—$-1.01—-8.9%
Oct 29, 2025—$-0.74—+4.0%
Jul 30, 2025—$-0.80—+30.9%
Apr 30, 2025—$-0.77—-10.9%
Feb 20, 2025—$-0.90—-0.7%
Nov 6, 2024—$-0.88—+1.7%
Aug 7, 2024—$-0.84—-3.6%
May 9, 2024—$-0.94—+13.4%
Feb 22, 2024—$-1.58—-2.3%
Nov 6, 2023—$-0.73—+7.9%
Aug 3, 2023—$-0.67—-5.9%
May 9, 2023—$-1.30—+14.0%
Feb 23, 2023—$-1.37—+11.1%
Nov 3, 2022—$-1.58—+13.3%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related